|
Dr Ian McDonald has 25 years' international experience in managing drug discovery and design teams in Europe and USA. He was most recently Vice President of Drug Discovery at Structural GenomiX, USA. Prior experience includes a similar position at Structural Bioinformatics, Vice President of Chemistry with responsibilities for medicinal and bio-chemistry at SIBIA Neuroscience (now part of Merck Research Laboratories) and Merrell Dow (now part of Sanofi-Aventis). Under his leadership, six compounds have been developed and evaluated in clinical trials.
Ian was awarded his BSc and PhD degrees in chemistry from the University of Western Australia and has co-authored over 74 peer-reviewed manuscripts and book chapters, and is an inventor on 38 issued US patents. | 